HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MPT0G211

HDAC6 inhibitor
Also Known As:
N-hydroxy-4-((quinolin-8-ylamino)methyl)benzamide
Networked: 3 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Liou, Jing-Ping: 3 articles (01/2019 - 01/2018)
2. Yang, Chia-Ron: 3 articles (01/2019 - 01/2018)
3. Pan, Shiow-Lin: 2 articles (01/2019 - 12/2018)
4. Tu, Huang-Ju: 2 articles (01/2019 - 12/2018)
5. Hsieh, Yi-Ling: 1 article (01/2019)
6. Chao, Min-Wu: 1 article (12/2018)
7. Chen, Yi-Ying: 1 article (12/2018)
8. Lin, Mei-Hsiang: 1 article (12/2018)
9. Lin, Yi-Jyun: 1 article (12/2018)
10. Sung, Ting-Yi: 1 article (12/2018)

Related Diseases

1. Leukemia
2. Alzheimer Disease (Alzheimer's Disease)
3. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
4. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Vincristine (Oncovin)
2. Doxorubicin (Adriamycin)
3. Histone Deacetylase 6
4. Histones (Histone)
5. Acetylesterase

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)